Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor and the Section Editor for this issue.
Hal E. Broxmeyer
Dr Hal E. Broxmeyer is Distinguished Professor, Professor of Microbiology and Immunology (Full-Time), Mary Margaret Walther Professor Emeritus, and Co-Leader (1993–2019) Program on Hematopoiesis and Hematological Malignancies, NCI-Designated Comprehensive Indiana University Simon Cancer Center (IUSCC), and currently, Senior Advisor to IUSCC Director, and former Chairman of Microbiology and Immunology and Scientific Director, Walther Oncology Center, at the Indiana University School of Medicine, Indianapolis, IN. He received a BS degree, Brooklyn College, City University of New York in 1966, an MS degree from Long Island University, Brooklyn Center in 1969 and a PhD from New York University in 1973. He did post-doctoral training in 1973–1975 at Kingston General Hospital, Queens University Kingston, Ontario, Canada. From 1975–1983 he worked at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City rising from the rank of Associate Researcher to that of Associate Member. He was also Assistant Professor of Biology, Sloan Kettering Division of Cornell University Graduate School of Medical Sciences, New York, before being recruited to the Indiana University School of Medicine in 1983 as an Associate Professor of Medicine. To date, he has published 803 scientific papers (547 refereed papers and 256 Reviews/Book Chapters). Broxmeyer's laboratory studies mechanisms regulating hematopoietic stem and progenitor cells, embryonic stem cells and induced pluripotent stem cells: proliferation, self-renewal, survival, differentiation and migration (homing/mobilization). He was involved in establishing the field of cord blood transplantation. His publications have been cited >65,747 times (Google Scholar; GS); H-Factor for publications is 120 (GS) with i10 index = 584 (GS).
Dr Broxmeyer's Awards include: New York University Founders Day Award (1973); Mellor Award (2nd prize 1976; 1st prize 1977) and Boyer Award (1983) from MSKCC; Special Fellow (1976–1978) and Scholar Award (1978–1983) from the Leukemia Lymphoma Society; Merit Award, National Cancer Institute (1987–1995); Variety Club Award (1992 and 1993), Indiana; Gold Medal of City of Paris (1993); World of Difference Award, Indiana Health Industry Forum (1997); Who's Who in Health Care, Indianapolis Business Journal (IBJ) (2002); Health Care Heroes Award, IBJ (2002); Karl Landsteiner Award, American Association of Blood Banks (2002); Prestigious External Award Recognition, IUPUI (2003); Distinguished Alumni Award, Long Island University (2005); Joseph T. Taylor Excellence in Diversity Award, Indiana University (2006); Dirk van Bekkum Award, Autologous Blood and Bone Marrow Society (2006); E. Donnall Thomas Prize and Lecture, American Society of Hematology (2007); Glenn W. Irwin Jr. M.D., Distinguished Faculty Award, Indiana University School of Medicine Alumni Association (2008); State of Indiana General Assembly House Resolution No. 46 (2008); Mission Advancement Award, Leukemia Lymphoma Society (2008); Cord Blood Pioneering Award, Int. Cord Blood Symposium (2008); Till and McCullough Award, Canadian Bone Marrow Transplant Group (2010); Donald Metcalf Award, Int. Soc. Expt. Hematol. (2011); Elected Fellow of the American Association for the Advancement of Science (AAAS) (2013); Honorary Professorship, Peking Union Medical College, Beijing, China (2014); Thought Leader Award, 15th Annual Cord Blood Symposium (2017); NHLBI Outstanding Investigator Award (R35) (2018); IU President's Medal of Honor; highest honor given by IU (2019); Lifetime Achievement Award, Cord Blood Association (2019); and Daughter's of the American Revolution Medal of Honor, their highest honor (2019).
Dr Broxmeyer is a former President of the American Society of Hematology (ASH; 2010), former President of the International Society for Experimental Hematology and Stem Cell Research (ISEH, 1990, 1991), former Chairman, and member, Board of Scientific Councilors, National Space Biomedical Research Institute (NSBRI/NASA, 1998–2006), and Chairman Emeritus, Board of Directors, National Disease Research Interchange, Philadelphia, PA.
Maegan L. Capitano
Dr Maegan L. Capitano is an Assistant Research Professor in the Department of Microbiology and Immunology at Indiana University School of Medicine. She earned her B.A. in Biology from St. Mary's Honors College of Maryland in 2004. During her summers in college, she worked at Memorial Sloan Kettering Cancer Center in the laboratory of Dr Bo Dupont as a laboratory technician where she developed a passion for research. She next went on to earn a M.S. in Natural Science-Oncology in 2006 and her Ph.D. in Microbiology and Immunology in 2012 at the State University of New York- Roswell Park Cancer Center Division under the mentorship of Dr Elizabeth Repasky where she was given the George Meyer's Award for Proficiency and Academic Excellence in Immunology. She received her post-doctoral training (2012–2016) in the laboratory of Dr Hal E. Broxmeyer at Indiana University School of Medicine focusing on Experimental Hematology. In the fall of 2016, she joined the faculty of the Department of Microbiology and Immunology at Indiana University School of Medicine as an Assistant Research Professor. Dr Capitano has published 22 primary research articles and 6 invited reviews articles/book chapters. In addition to her laboratory research, Dr Capitano served on the Trainee Council for the American Society of Hematology, a committee made up of two Ph.D.s and ten M.D.s that are in the earlier stages of their careers in Hematology. Dr Capitano's research focuses on discovering potential new agents that regulate hematopoietic stem and progenitor cell migration, proliferation, differentiation and survival capacity under normal and stressed conditions.